130 related articles for article (PubMed ID: 10196013)
1. Double-blind, placebo-controlled study of growth hormone treatment in elderly patients undergoing chronic hemodialysis: anabolic effect and functional improvement.
Johannsson G; Bengtsson BA; Ahlmén J
Am J Kidney Dis; 1999 Apr; 33(4):709-17. PubMed ID: 10196013
[TBL] [Abstract][Full Text] [Related]
2. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.
Hansen TB; Gram J; Jensen PB; Kristiansen JH; Ekelund B; Christiansen JS; Pedersen FB
Clin Nephrol; 2000 Feb; 53(2):99-107. PubMed ID: 10711411
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of growth hormone therapy in malnourished hemodialysis patients.
Kotzmann H; Yilmaz N; Lercher P; Riedl M; Schmidt A; Schuster E; Kreuzer S; Geyer G; Frisch H; Hörl WH; Mayer G; Luger A
Kidney Int; 2001 Oct; 60(4):1578-85. PubMed ID: 11576376
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
6. The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.
Cuneo RC; Judd S; Wallace JD; Perry-Keene D; Burger H; Lim-Tio S; Strauss B; Stockigt J; Topliss D; Alford F; Hew L; Bode H; Conway A; Handelsman D; Dunn S; Boyages S; Cheung NW; Hurley D
J Clin Endocrinol Metab; 1998 Jan; 83(1):107-16. PubMed ID: 9435425
[TBL] [Abstract][Full Text] [Related]
7. Discontinuing long-term GH replacement therapy--a randomized, placebo-controlled crossover trial in adult GH deficiency.
Filipsson Nyström H; Barbosa EJ; Nilsson AG; Norrman LL; Ragnarsson O; Johannsson G
J Clin Endocrinol Metab; 2012 Sep; 97(9):3185-95. PubMed ID: 22791760
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone versus placebo treatment for one year in growth hormone deficient adults: increase in exercise capacity and normalization of body composition.
Jørgensen JO; Vahl N; Hansen TB; Thuesen L; Hagen C; Christiansen JS
Clin Endocrinol (Oxf); 1996 Dec; 45(6):681-8. PubMed ID: 9039333
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human growth hormone treatment in elderly patients undergoing elective total hip replacement.
Weissberger AJ; Anastasiadis AD; Sturgess I; Martin FC; Smith MA; Sönksen PH
Clin Endocrinol (Oxf); 2003 Jan; 58(1):99-107. PubMed ID: 12519419
[TBL] [Abstract][Full Text] [Related]
11. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.
Gravholt CH; Naeraa RW; Brixen K; Kastrup KW; Mosekilde L; Jørgensen JO; Christiansen JS
Pediatrics; 2002 Nov; 110(5):889-96. PubMed ID: 12415026
[TBL] [Abstract][Full Text] [Related]
12. Lipids, blood pressure and bone metabolism after growth hormone therapy in elderly hemodialysis patients.
Viidas U; Johannsson G; Mattson-Hultén L; Ahlmén J
J Nephrol; 2003; 16(2):231-7. PubMed ID: 12768070
[TBL] [Abstract][Full Text] [Related]
13. Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.
Ahmad AM; Hopkins MT; Thomas J; Ibrahim H; Fraser WD; Vora JP
Clin Endocrinol (Oxf); 2001 Jun; 54(6):709-17. PubMed ID: 11422104
[TBL] [Abstract][Full Text] [Related]
14. Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men.
Vittone J; Blackman MR; Busby-Whitehead J; Tsiao C; Stewart KJ; Tobin J; Stevens T; Bellantoni MF; Rogers MA; Baumann G; Roth J; Harman SM; Spencer RG
Metabolism; 1997 Jan; 46(1):89-96. PubMed ID: 9005976
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone treatment in hemodialysis patients--a randomized, double-blind, placebo-controlled study.
Ericsson F; Filho JC; Lindgren BF
Scand J Urol Nephrol; 2004; 38(4):340-7. PubMed ID: 15669595
[TBL] [Abstract][Full Text] [Related]
16. Does growth hormone allow more efficient nitrogen sparing in postoperative patients requiring parenteral nutrition? A double-blind, placebo-controlled randomised trial.
Sevette A; Smith RC; Aslani A; Kee AJ; Hansen R; Barratt SM; Baxter RC
Clin Nutr; 2005 Dec; 24(6):943-55. PubMed ID: 16083996
[TBL] [Abstract][Full Text] [Related]
17. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
Khorram O; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
[TBL] [Abstract][Full Text] [Related]
18. Serum leptin response to the acute and chronic administration of growth hormone (GH) to elderly subjects with GH deficiency.
Gill MS; Toogood AA; Jones J; Clayton PE; Shalet SM
J Clin Endocrinol Metab; 1999 Apr; 84(4):1288-95. PubMed ID: 10199769
[TBL] [Abstract][Full Text] [Related]
19. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults.
Kim KR; Nam SY; Song YD; Lim SK; Lee HC; Huh KB
Horm Res; 1999; 51(2):78-84. PubMed ID: 10352397
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone (GH) replacement therapy in adult-onset gh deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial.
Hoffman AR; Kuntze JE; Baptista J; Baum HB; Baumann GP; Biller BM; Clark RV; Cook D; Inzucchi SE; Kleinberg D; Klibanski A; Phillips LS; Ridgway EC; Robbins RJ; Schlechte J; Sharma M; Thorner MO; Vance ML
J Clin Endocrinol Metab; 2004 May; 89(5):2048-56. PubMed ID: 15126520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
